ASX Share rice
Sun 16 May 2021 - 07:10:am (Sydney)

GSS Share Price

GENETIC SIGNATURES LIMITEDGSSPharmaceuticals, Biotechnology & Life Sciences

GSS Company Information


Genetic Signatures Limited




Diagnostics & Research

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services


7 Eliza Street Sydney NSW Australia 2042


61 2 9870 7580

MD, CEO & Exec. Director:

Dr. John R. Melki

CFO & Company Sec.:

Mr. Peter Manley

Exec. Director of US Operations & Exec. Director:

Mr. Michael Anton Aicher M.B.A., BSc, MBA

Founder & Chairman Emeritus:

Mr. Christopher M. Abbott

Chief Scientific Officer:

Dr. Douglas S. Millar BSc, Ph.D.

Director of Global Sales & Marketing:

Mr. Jackson Jones

US Market Consultant:

Mr. Patrick Noland BSc, MBA

Company Overview:

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in North America and Australia. The company designs and manufactures a suite of real-time polymerase chain reaction based products for detection of infectious diseases under EasyScreen brand name. It also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. Genetic Signatures Limited was founded in 2001 and is headquartered in Sydney, Australia.

GSS Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


GSS CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Change To Inventory:


Change To Account Receivables:


Sale Purchase Of Stock:


Capital Expenditures:


GSS Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Total Revenue:


Cost Of Revenue:


GSS Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Liabilities:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


GSS Share Price History

GSS News

06 Apr, 2021
It is hard to get excited after looking at Genetic Signatures' (ASX:GSS) recent performance, when its stock has...
05 Feb, 2021
For us, stock picking is in large part the hunt for the truly magnificent stocks. Mistakes are inevitable, but a single...
31 Dec, 2020
With the business potentially at an important milestone, we thought we'd take a closer look at Genetic Signatures...
25 Nov, 2020
A look at the shareholders of Genetic Signatures Limited (ASX:GSS) can tell us which group is most powerful. Generally...
20 Oct, 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
15 Sep, 2020
This article will reflect on the compensation paid to John Melki who has served as CEO of Genetic Signatures Limited...
31 Jul, 2020
Genetic Signatures Limited (ASX:GSS) shareholders will have a reason to smile today, with the covering analyst making...